S21-400 Chemically Modified Bacterial Peptidoglycan Compositions and Uses thereof Technology Reference CZ Biohub SF ref. no. CZB-231S Stanford ref. no. S21-400 Researchers at Stanford have developed a new microparticle vaccine scaffold for the development of immunogenic subunit vaccines. Peter Kim Carolyn Bertozzi Frances Rodriguez-Rivera Payton Weidenbacher